Use of glycopyrrolate in the treatment of Meniere's disease

Laryngoscope

Volumn 108, Issue 10, 1998, Pages 1442-1445

  Storper, Ian S ^a   Spitzer, Jaclyn B ^a   Scanlan, Mark ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPYRRONIUM BROMIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ELECTRONYSTAGMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT OUTCOME; VERTIGO;

ADULT; AGED; AUDIOMETRY; FEMALE; GLYCOPYRROLATE; HUMANS; MALE; MENIERE'S DISEASE; MIDDLE AGED; PARASYMPATHOLYTICS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VERTIGO;

EID: 0031686593     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199810000-00004     Document Type: Article

References (15)

1. Meniere MP. Maladies de l'orielle interne offrant les symptoms de la congestion cerebrale apoplectiforme. Gaz Med Paris 1861;16:55-9.
2. Cawthorne TE. Meniere's disease. Ann Otol Rhinol Laryngol 1947;56:18-38.
3. Lindsay JB. Labyrinthine dropsy. Laryngoscope 1946;56: 325-41.
4. Jackson CG, Glasscock ME III, Davis WE, et al. Medical Management of Meniere's disease. Ann Otol Rhinol Laryngol 1981;90(2, Pt 1):142-7.
5. Baloh RW, Honrubia V. Endolymphatic hydrops (Meniere's Syndrome). In: Baloh RW, Honrubia V, eds, Clinical Neurophysiology of the Vestibular System. edn 2. Philadelphia: FA Davis; 1990:214-9.
6. Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
7. Jacobson GP, Newman CW. The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 1990;116:424-7.
8. Newman CW, Jacobson GP, Spitzer JB. Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg 1996;122:143-8.
9. Buckelew SP, DeGood DE, Schwartz DP, et al. Cognitive and somatic item response pattern of pain patients, psychiatric patients, and hospital employees. J Clin Psychol 1986; 42: 852-60.
10. Beck AT, Rial WY, Rickels K. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 1974;7:151-69.
11. Wyant GM, Kao E. Glycopyrrolate methobromide. Part 1. Effect on salivary secretion. Can Anaesth Soc J 1974;21: 230-41.
12. Ragamurthy S, Ylagan LB, Winnie AP. Glycopyrrolate as a substitute for atropine: a preliminary report. Anesth Analg 1971;50:732-6.
13. Kveton JF. Surgical treatment of peripheral vestibular disorders. In: Glasscock ME III, Shambaugh Jr, GE, eds. Surgery of the Ear. Philadelphia: WB Saunders; 1990:467-501.
14. Wackym PA, Blackwell KE, Nyerges AM. Pharmacotherapy of vestibular dysfunction. In: Jackler RK, Brackmann DE, eds. Neurotology. Baltimore: Mosby, 1994:543-53.
15. Oxford AW, Bell JA, Kilpatrick GJ, et al. Ondansetron and related 5-HT3 antagonists: recent advances. Prog Med Chem 1992;29:239-70.